We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000060:SSEShenzhen Zhongjin Lingnan Nonfemet Co. Ltd. Analysis

Data as of 2026-07-15 - not real-time

CN¥6.26

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading below its 20‑day and 50‑day moving averages while still above the 200‑day average, indicating a neutral to slightly bearish trend. RSI sits in the mid‑30s, suggesting modest oversold pressure, and the MACD histogram remains negative, reinforcing bearish momentum. Beta is well below one, pointing to lower market sensitivity, yet 30‑day volatility exceeds seventy percent, implying a choppy price environment. The PE ratio approaches the high‑30s, while the forward PE drops into the low‑20s, hinting at expected earnings improvement but still relatively pricey. Dividend yield is under one percent with a payout ratio below forty percent, making the dividend modest but potentially sustainable given positive free cash flow. However, debt‑to‑equity exceeds one hundred percent, highlighting a leverage concern that could strain cash generation, and operating margins are thin with a low net profit margin. Analyst coverage is minimal with no consensus recommendation, and recent news is silent, leaving fundamentals as the primary guide. Market sentiment index reads extreme greed, which may be inflating price despite fundamentals.
Given the mixed signals, the stock appears overvalued with notable downside risk, but its revenue growth and improving forward earnings provide a modest upside floor.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • price below short‑term moving averages
  • negative MACD histogram
  • high short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • strong revenue growth
  • forward earnings improvement
  • elevated leverage and thin margins

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • sustainable dividend with modest payout
  • potential benefit from industry growth
  • persistent debt burden and commodity cyclicality

Key Metrics & Analysis

Financial Health

Revenue Growth21.40%
Profit Margin1.62%
P/E Ratio27.2
ROE5.25%
ROA2.50%
Debt/Equity102.34
P/B Ratio1.4
Op. Cash FlowCN¥1.7B
Free Cash FlowCN¥246.9M

Technical Analysis

TrendNeutral
RSI36.5
SupportCN¥6.07
ResistanceCN¥8.91
MA 20CN¥7.34
MA 50CN¥7.51
MA 200CN¥6.52
MACDBearish
VolumeDecreasing
Fear & Greed Index93.45

Valuation

Target PriceCN¥7.69
Upside/Downside22.84%
GradeOvervalued
TypeGrowth
Dividend Yield0.88%

Risk Assessment

Beta0.44
Volatility71.06%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.